Treatment and Outcome(s) of a Large Cohort of Italian Patients (pts) with Poor-Risk Metastatic Renal Cell Carcinoma (Prrcc).
Journal of clinical oncology(2014)
Abstract
Aim: With the exception of the Temsirolimus (Tem) registration trial, prRCC is grossly underrepresented in clinical trials.
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined